Kanada - angielski - Health Canada

rafter 8 products inc - vitamin b12; ferric ammonium citrate; vitamin b1 (thiamine hydrochloride); vitamin b2 (riboflavin 5'-phosphate sodium); vitamin b6 (pyridoxine hydrochloride); nicotinamide; dexpanthenol; cobalt (cobalt gluconate); copper gluconate - solution - 150mcg; 15mg; 40mg; 4mg; 10mg; 100mg; 15mg; 0.7mg; 0.2mg - vitamin b12 150mcg; ferric ammonium citrate 15mg; vitamin b1 (thiamine hydrochloride) 40mg; vitamin b2 (riboflavin 5'-phosphate sodium) 4mg; vitamin b6 (pyridoxine hydrochloride) 10mg; nicotinamide 100mg; dexpanthenol 15mg; cobalt (cobalt gluconate) 0.7mg; copper gluconate 0.2mg - vitamins with minerals - cattle; swine (pigs); goats; horses; cats; sheep; wild/miscellaneous; dogs

Kanada - angielski - Health Canada

vetoquinol n a inc - ferric ammonium citrate; thiamine hydrochloride; vitamin b12; nicotinamide; liver extract; cobalt gluconate; copper gluconate - solution - 10mg; 2mg; 25mcg; 20mg; 25mg; .05mg; 5mcg - ferric ammonium citrate 10mg; thiamine hydrochloride 2mg; vitamin b12 25mcg; nicotinamide 20mg; liver extract 25mg; cobalt gluconate .05mg; copper gluconate 5mcg - vitamins & minerals - horses

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

coopersurgical, inc. - ferric subsulfate (unii: 3qj8ws6v8h) (ferric cation - unii:91o4lml611) - ferric cation 259 mg in 1 g - ferric subsulfate, aqueous, is a stypic agent used for achieving local hemostasis. in punch biopsies of the full dermis, the time to achieve hemostasis is typically less than 20 seconds.1 one method of applying ferric subsulfate solution for dermal use consists of the physician placing fingers at the opposite edge of the wound and stretching the skin. the wound is then wiped with gauze, the ferric subsulfate solution applied, and the tension maintained for approximately 15 seconds. 2

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

rosemont pharmaceuticals ltd - ferric ammonium citrate; folic acid - oral solution - 80mg/1ml ; 500microgram/1ml

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

rosemont pharmaceuticals ltd - ferric ammonium citrate; folic acid - oral solution - 80mg/1ml ; 100microgram/1ml

Zjednoczone Emiraty Arabskie - angielski - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

ferric ammonium citrate, cholecalciferol, magnesium gluconate, l-ascorbic acid (vitamin c), cupric gluconate, retinyl palmitate (vitamin a), potassium chloride -

Australia - angielski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

inca (flight) co pty ltd - cobalt as cobaltous sulfate heptahydrate; copper present as copper sulfate pentahydrate; iron as ferric ammonium citrate, ferrous gluconate, ferr; manganese as manganese sulfate monohydrate - oral solution/suspension - cobalt as cobaltous sulfate heptahydrate mineral-cobalt active 0.2 mg/l; copper present as copper sulfate pentahydrate mineral-copper active 14.7 mg/l; iron as ferric ammonium citrate, ferrous gluconate, ferr mineral-iron active 16.0 g/l; manganese as manganese sulfate monohydrate mineral-manganese active 14.9 mg/l - nutrition & metabolism - dog - greyhound | horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | - iron supplement

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

rockwell medical, inc - ferric pyrophosphate citrate (unii: uby79oco9g) (ferric cation - unii:91o4lml611) - triferic is an iron replacement product indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (hdd-ckd). triferic is not intended for use in patients receiving peritoneal dialysis. triferic has not been studied in patients receiving home hemodialysis. none risk summary there are no data on triferic use in pregnant women to inform a drug-associated risk of major birth defects and miscarriage. in pregnant rats and rabbits, ferric pyrophosphate citrate caused adverse developmental outcomes at maternally toxic dose levels that were higher than the maximum theoretical amount of iron transferred to patients from triferic. use triferic during pregnancy only if the potential benefit justifies the potential risk to the fetus. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background of birth defect, loss, or other adverse outcomes. in the us. general populati

Stany Zjednoczone - angielski - NLM (National Library of Medicine)

rockwell medical inc. - ferric pyrophosphate citrate (unii: uby79oco9g) (ferric cation - unii:91o4lml611) - triferic avnu is an iron replacement product indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (hdd-ckd). limitations of use - triferic avnu is not intended for use in patients receiving peritoneal dialysis. - triferic avnu  has not been studied in patients receiving home hemodialysis. none risk summary there are no available data on triferic avnu usein pregnant women to inform a drug-associated risk of major birth defects,  miscarriage or adverse maternal or fetal outcomes. in animal reproduction studies, intravenous administration of ferric pyrophosphate citrate to pregnant rats and rabbits during organogenesis caused adverse developmental outcomes at maternally toxic dose levels that were higher than the maximum theoretical amount of iron transferred to patients from triferic avnu (see data) .  the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregna

Wielka Brytania - angielski - MHRA (Medicines & Healthcare Products Regulatory Agency)

wallace manufacturing chemists ltd - ferric ammonium citrate; thiamine hydrochloride; riboflavin; pyridoxine hydrochloride; nicotinamide; calcium pantothenate; calcium glycerophosphate; sodium glycerophosphate; potassium glycerophosphate; manganese glycerophosphate - oral solution - 50mg/1ml ; 100microgram/1ml ; 50microgram/1ml ; 25microgram/1ml ; 750microgram/1ml ; 25microgram/1ml ; 2.15mg/1ml ; 4.25mg/1ml ; 350microgram/1ml ; 200microgram/1ml